XERIS PHARMACEUTICALS INC Share-based Payment Arrangement, Expense
XERIS PHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $2.51 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2021-06-30 was $2.51M, a 21.29% increase year-over-year.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2021-03-31 was $2.46M, a 22.56% increase year-over-year.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2020-12-31 was $2.14M, a 16.18% increase year-over-year.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2020-09-30 was $2.05M, a 14.49% increase year-over-year.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2020 was $8.27M, a 27.59% increase from fiscal 2019.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2019 was $6.48M, a 275.23% increase from fiscal 2018.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2018 was $1.73M, a 246.29% increase from fiscal 2017.
- XERIS PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2017 was $499.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2021-06-30 | $2.51M 10-Q · filed 2021-08-05 | $4.97M 10-Q · filed 2021-08-05 | $7.11M derived: sum of 3 quarters · filed 2021-08-05 | $9.17M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $2.46M 10-Q · filed 2021-05-13 | $4.60M derived: sum of 2 quarters · filed 2021-05-13 | $6.66M derived: sum of 3 quarters · filed 2021-05-13 | $8.73M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $4.19M derived: sum of 2 quarters · filed 2021-03-09 | $6.26M derived: sum of 3 quarters · filed 2021-08-05 | $8.27M 10-K · filed 2021-03-09 |
| 2020-09-30 | $2.05M 10-Q · filed 2020-11-09 | $4.13M derived: sum of 2 quarters · filed 2021-08-05 | $6.13M 10-Q · filed 2020-11-09 | $7.97M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $2.07M 10-Q · filed 2021-08-05 | $4.08M 10-Q · filed 2021-08-05 | $5.92M derived: sum of 3 quarters · filed 2021-08-05 | $7.71M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $2.01M 10-Q · filed 2021-05-13 | $3.85M derived: sum of 2 quarters · filed 2021-05-13 | $5.64M derived: sum of 3 quarters · filed 2021-05-13 | $7.34M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $3.64M derived: sum of 2 quarters · filed 2021-03-09 | $5.34M derived: sum of 3 quarters · filed 2021-03-09 | $6.48M 10-K · filed 2021-03-09 |
| 2019-09-30 | $1.79M 10-Q · filed 2020-11-09 | $3.50M derived: sum of 2 quarters · filed 2020-11-09 | $4.64M 10-Q · filed 2020-11-09 | $5.22M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $1.70M 10-Q · filed 2020-08-10 | $2.85M 10-Q · filed 2020-08-10 | $3.43M derived: sum of 3 quarters · filed 2020-08-10 | $3.97M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $1.15M 10-Q · filed 2020-05-07 | $1.73M derived: sum of 2 quarters · filed 2020-05-07 | $2.27M derived: sum of 3 quarters · filed 2020-05-07 | $2.63M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.12M derived: sum of 2 quarters · filed 2020-03-12 | $1.48M derived: sum of 3 quarters · filed 2020-03-12 | $1.73M 10-K · filed 2020-03-12 |
| 2018-09-30 | $544.00K 10-Q · filed 2019-11-07 | $905.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.15M 10-Q · filed 2019-11-07 | $1.30M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $361.00K 10-Q · filed 2019-08-06 | $605.00K 10-Q · filed 2019-08-06 | $753.00K derived: sum of 3 quarters · filed 2019-08-06 | $857.00K derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $244.00K 10-Q · filed 2019-05-09 | $392.00K derived: sum of 2 quarters · filed 2019-05-09 | $496.00K derived: sum of 3 quarters · filed 2019-05-09 | $585.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $252.00K derived: sum of 2 quarters · filed 2019-03-06 | $341.00K derived: sum of 3 quarters · filed 2019-03-06 | $499.00K 10-K · filed 2019-03-06 |
| 2017-09-30 | $104.00K 10-Q · filed 2018-11-08 | $193.00K derived: sum of 2 quarters · filed 2018-11-08 | $351.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $89.00K 10-Q · filed 2018-08-14 | $247.00K 10-Q · filed 2018-08-14 |